Vor Biopharma confirms VOR33 engraftment and hematological protection data to be announced later this year

Vor Biopharma Inc.

Vor Biopharma presented at Piper Sandler 34th Annual Healthcare Conference on November 29, 2022.
Company confirmed upcoming VOR33 data will include engraftment data and hematological protection data.
Data follows treatment with Mylotarg in at least one patient.
VOR33 data expected to be announced later this year.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.